Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients1 New findings from this investigational…
Completed Enrollment in First-In-Human Phase I study of Less Invasive Approach Expected to Present 6-Month data in 2026 at a…
World’s First Approved Polymer Heart Valve Now Available at Select CentersGOA, India--(BUSINESS WIRE)--#TRIAheartvalves--Foldax® Inc., a leader in the development of…
Dévoilement de la politique bioalimentaire 2025-2035 August 22, 2025 12:52 ET | Source: Collectif Vital MONTRÉAL, Aug. 22, 2025 (GLOBE…
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable…